To,
The Members,
Your Directors have the pleasure in presenting 3 rd Annual Report of Biopol Chemicals Limited (the Company ) on the Business and Operations of your Company together with the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026.
1. FINANCIAL RESULTS:
The financial performance (standalone) for the year ended 31 st March,2026 is summarized below:
(In Lakhs)
| Particulars | 2025-26 | 2024-25 |
| Revenue from Operations | 8,114.33 | 4,922.13 |
| Other Income | 22.83 | - |
| Total Revenue | 8,137.16 | 4,922.13 |
| Profit before Depreciation, Finance Costs, Exceptional Items and Tax Expense | 1,367.75 | 647.71 |
| Less: Depreciation/ Amortization/ Impairment | 9.83 | 9.19 |
| Profit before Finance Costs, Exceptional Items and Tax Expense | 1,357.92 | 638.51 |
| Less: Finance Costs | 152.08 | 60.47 |
| Profit before Exceptional Items and Tax Expense | 1,205.84 | 578.04 |
| Add/(less): Exceptional items | 0 | 0 |
| Profit before Tax Expense | 1,205.84 | 578.04 |
| Less: Tax Expense | ||
| Current Tax | 309.53 | 147.78 |
| Deferred Tax | (1.10) | (0.97) |
| Profit for the year (1) | 897.41 | 431.23 |
| Other Comprehensive Income/loss (2) | 0 | 0 |
| Total (1+2) | 897.41 | 431.23 |
| EPS (basic and diluted) | 10.83 | 5.45 |
Note: Previous year figures regrouped or rearranged wherever necessary.
2. FINANCIAL PERFORMANCE:
During the financial year 2025-26, the Company recorded Total Revenue of Rs. 8,137.16 Lakhs, as compared to Rs. 4,922.13 Lakhs in the previous financial year, registering an increase of Rs. 3,215.03 Lakhs (approximately 65.32%).
? I O p ? L.
The Profit Before Tax (PBT) for the financial year stood at Rs. 1,205.84 Lakhs as against Rs. 578.04 Lakhs in the previous financial year, reflecting an increase of Rs. 627.96 Lakhs (approximately 108.60%).
The Profit After Tax (PAT) for the financial year was Rs. 897.41 Lakhs, compared to Rs. 431.23 Lakhs in the previous financial year, registering a growth of Rs. 466.18 Lakhs (approximately 108.10%).
3. TRANSFER TO RESERVES:
The Board of Directors of your company has decided not to transfer any amount to the Reserves for the year under review.
4. DIVIDEND:
With a view to meet future requirements of projects and to strengthen the financial position of the Company, the Board of Directors have decided not to recommend any dividend on Equity Shares of the Company for the financial year ended March 31, 2026.
5. PUBLIC DEPOSITS:
During the year under review, the Company has neither accepted any deposits nor there were any amounts outstanding at the beginning of the year which were classified as Deposits in terms of Section 73 of the Act read with the Companies (Acceptance of Deposit) Rules, 2014 and hence, the requirement for furnishing of details of deposits which are not in compliance with the Chapter V of the Companies Act, 2013 is not applicable.
6. REGISTERED OFFICE ADDRESS AND CORPORATE OFFICE ADDRESS:
There was no change in the Registered Office of the Company during the Financial Year under review.
However, subsequent to the closure of the Financial Year, the Company shifted its Registered Office from D-211, 2nd Floor, Block-D, Sumel Business Park-6, Near Dudheshwar Circle, Ahmedabad- 380004, Gujarat, India to Plot No. 123 & 124, G.I.D.C. Phase-1, Vatva, Daskroi, Ahmedabad - 382445, Gujarat, India.
Accordingly, the Registered Office of the Company is presently situated at Plot No. 123 & 124, G.I.D.C. Phase-1, Vatva, Daskroi, Ahmedabad - 382445, Gujarat, India.
During the Financial Year under review, the Company shifted its Corporate Office from 74, Nilgunj Road, Agarpara, North 24 Parganas, West Bengal - 700109, India to Unit No. 2ES3B1, 2nd Floor, Mani Casadona, Street No. 372, Action Area 1, IIF Newtown, Alia University, New Town, North 24 Parganas, West Bengal - 700156, India, with effect from 19th August, 2025.
Accordingly, the Corporate Office of the Company is presently situated at Unit No. 2ES3B1, 2nd Floor, Mani Casadona, Street No. 372, Action Area 1, IIF Newtown, Alia University, New Town, North 24 Parganas, West Bengal - 700156, India.
7. BUSINESS OVERVIEW:
Our Company is engaged in the manufacturing and distribution of specialty chemicals across four key categories, namely silicones, emulsifiers, biochemicals and polyelectrolytes. The Companys product portfolio comprises 66 products, including 40 silicone-based products, 5 emulsifier-based products, 15 biochemical products and 6 polyelectrolyte products.
The Companys products cater to diverse industry segments, including textiles, home care, agriculture and industrial chemicals. These products are used in applications such as textile softeners, emulsions and hardeners; silicone fluids and cleaning chemicals for home care; silicone adjuvants and surfactants for agriculture; and release agents for industrial applications.
In addition to product manufacturing, the Company provides technical consultancy services to customers, including support in specialty chemical applications, textile processing, dye manufacturing and industrial formulations.
The Company operates through a business-to-business (B2B) model, serving institutional customers across domestic and international markets through direct sales and a network of distributors. In India, the Company has a presence across key regions including West Bengal, Gujarat, Maharashtra, Tamil Nadu and Karnataka, with significant revenue contribution from West Bengal and Gujarat. The Company also exports its products, with a focus on Bangladesh, a prominent hub for textile and apparel manufacturing.
8. CHANGE IN THE NATURE OF BUSINESS:
There has been no change in the Business of the Company during the financial year ended March 31, 2026.
9. INITIAL PUBLIC OFFER (IPO) AND LISTING OF EQUITY SHARES:
During the financial year under review, the Company successfully completed its Initial Public Offering (IPO) by issuing 28,94,400 Equity Shares.
Pursuant to the successful completion of the IPO, the Equity Shares of the Company were listed and admitted for trading on the NSE SME Platform of the National Stock Exchange of India Limited with effect from February 13, 2026.
The listing represents a significant milestone in the Companys growth journey and provides the Company with enhanced visibility and access to capital markets.
10. CAPITAL STRUCTURE:
The capital Structure of the Company as on 31st March,2026:
| Share Capital | Amount in Rs. |
| 1. Authorized Share Capital: | |
| 12500000 Equity Shares (a) Re. 10/- each: | 12,50,00,000 |
| Total | 12,50,00,000 |
| 2. Issued/Subscribed and Fully Paid-up Share Capital: | |
| 10805400 Equity Shares (S> Rs. 10/- each fully paid up | 10,80,54,000 |
| Total | 10,80,54,000 |
Authorized Share Capital
There was no change in the Authorized Share Capital of the Company during the financial year 2025-26.
• Issued/Subscribed and Fully Paid-up Share Capital
During the financial year 2025-26, the paid-up equity share capital of the Company increased pursuant to the successful Public Issue. The shareholders of the Company, at their meeting held on 8th September, 2025, approved the Public Issue and passed a special resolution authorizing the Company to undertake an Initial Public Offering (IPO) of equity shares aggregating up to Rs. 50 Crore, including the issue and allotment of equity shares of face value Rs. 10/- (Rupees Ten Only) each, in accordance with the applicable provisions of the Companies Act, 2013, the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, and other applicable laws.
Pursuant to the said approval, the Company issued 28,94,400 (Twenty-Eight Lakh Ninety- four Thousand Four Hundred) equity shares of face value Rs. 10/- (Rupees Ten only) each at an issue price of Rs. 108/- per equity share (including a securities premium of Rs. 98/- per equity share). The Board of Directors, at its meeting held on 11th February, 2026, approved the allotment of the aforesaid equity shares to the successful applicants under the Public Issue.
Consequent to the aforesaid allotment, the paid-up equity share capital of the Company increased from Rs. 7,91,10,000 (Rupees Seven Crore Ninety-One Lakhs Ten Thousand only) comprising 7911000 (Seventy-nine Lakh Eleven Thousand) equity shares of Rs. 10/- each, to Rs. 10,80,54,000 (Rupees Ten Crore Eighty Lakh Fifty-Four Thousand Only) comprising 10805400 (One Crore Eight Lakh Five Thousand Four Hundred) equity shares of Rs. 10/- each.
| s. No. | Particulars | Details |
| i | The Company has not bought back any of its securities during the year under review | Nil |
| ii | The Company has not issued any Sweat Equity Shares during the year under review | Nil |
| iii | No Bonus Shares were issued during the year under review | Nil |
| iv | The Company has not provided any Stock Option Scheme to the employees | Nil |
11. MATERIAL CHANGES AND COMMITMENTS BETWEEN THE END OF THE FINANCIAL YEAR OF THE COMPANY TO WHICH THE FINANCIAL STATEMENT RELATE AND THE DATE OF THIS REPORT:
There have been no material changes or commitments affecting the financial position of the Company that have occurred between the end of the Financial Year to which the financial statements relate and the date of this Report, except for changes in the composition of the Board of Directors. Subsequent to the close of the Financial Year, Ms. Vandan Vij Sarkar (DIN: 02198810) was appointed as a Non-Executive Non-Independent Director and Mr.
bn i ? p cm L
Sukhomoy Das (DIN: 11761165) was appointed as a Non-Executive Independent Director of the Company with effect from 11 June 2026. Subsequently, Ms. Vandan Vij Sarkar resigned from the office of Director of the Company with effect from 24 August 2026. The aforesaid changes have been appropriately disclosed in the relevant sections of this Annual Report.
12. WEB LINK OF ANNUAL RETURN, IF ANY:
Pursuant to Section 92(3) read with section 134(3) (a) of the Act, copies of the Annual Returns of the Company prepared in accordance with Section 92(1) of the Act read with Rule 11 of the Companies (Management and Administration) Rules, 2014 is hosted on the website of the Company at www.biopolchemicals.com .
13. DIRECTORS AND KEY MANAGERIAL PERSONNEL:
During the year under review and upto the date of this report the following changes were made in the composition of Board of Directors and Key Managerial Personnel of the Company. The details of Board at present and changes held during the FY 2025-26:
The Company places on record its appreciation for the valuable contribution made by the Directors and KMPs who ceased to hold office during the year and welcomes the newly appointed members to the Board and management team.
• Retirement by rotation and subsequent re-appointment
Mr. Vedant Sarkar (DIN: 10134523), Whole-time Director, is liable to retire by rotation at the ensuing Annual General Meeting, pursuant to Section 152(6) and other applicable provisions, if any, of the Companies Act, 2013, read with the Companies (Appointment and Qualification of Directors) Rules, 2014 (including any statutory modification(s) or re-enactment(s) thereof for the time being in force), and being eligible have offered himself for re-appointment.
Appropriate business for his re-appointment is being placed for the approval of the shareholders of the Company at the AGM. The brief resume of the Director and other related information has been detailed in the Notice convening the ensuing AGM of the Company.
• Change in Board Composition
During the financial year under review, the composition of the Board of Directors and Key Managerial Personnel of the Company underwent certain changes.
Mr. Brahma Ghosh Raval having (DIN: 10523186), Non-Executive Independent Director of the Company, resigned from the Board with effect from 31st May 2025.
Mr. Gaurav Mittal (DIN: 11281353) and Mr. Kaushikkumar Vasanthi Darji (DIN: 11283918) was appointed as Additional Non-Executive Independent Directors with effect from 6th September, 2025. They were subsequently regularised as Independent Directors as on 8th September, 2025.
Ms. Sruti Chanda (DIN: 10603438), Non-Executive Non Independent Director of the Company, resigned from the Board with effect from 06th September, 2025.
Ms. Preety Priya Ghosh (DIN: 09811959) Non-Executive Independent Director of the Company, resigned from the Board with effect from 18th March, 2026.
• Key Managerial Personnel (KMP)
During the year under review, the following changes took place in the Key Managerial Personnel of the Company:
Ms. Komal Khesakani Company Secretary and Compliance Officer of the Company resigned from the Company with effect from May 31st, 2025.
Ms. Deepti Nama has been appointed as a Company Secretary and Compliance Officer of the company, with effect from 6th September, 2025.
The composition of Board of Directors and Key Managerial Personnel (KMP) of the Company as on March 31, 2026 were as follows:
| Sr. No | Name of Director | Designation | Appointment / Resignation/Change in Designation | Date of Appointment at current designation/ Cessation/ Change in Designation |
| 1. | Santanu sarkar | Managing Director | No Change | 12/04/2023 |
| 2. | Vedant sarkar | Chairman and Whole-Time Director | No Change | 11/08/2023 |
| 3. | Brahma Ghosh Raval | Non-Executive Independent Director | Resignation | 31/05/2025 |
| 4. | Komal Khesakani | Company Secretary and Compliance Officer | Resignation | 31/05/2025 |
| 5. | Kaushikkumar Vasantbhai Darji | Non-Executive Independent Director | Change in Designation | 08/09/2025 |
| 6. | Gaurav Mittal | Non-Executive Independent Director | Change in Designation | 08/09/2025 |
| 7. | Sruti Chanda | Non-Executive Non Independent Director | Resignation | 06/09/2025 |
| 8. | Deepti Nama | Company Secretary and Compliance Officer | Appointment | 06/09/2025 |
| 9. | Sandip Choudhury | Chief Financial Officer | No Change | 17/06/2024 |
| 10. | Preety Priya Ghosh | Non-Executive Independent Director | Resignation | 18/03/2026 |
Changes After the Closure of Financial Year:
Subsequent to the close of the Financial Year, Ms. Vandan Vij Sarkar (DIN: 02198810) was appointed as a Non-Executive Non-Independent Director and Mr. Sukhomoy Das (DIN: 11761165) was appointed as a Non-Executive Independent Director of the Company with effect from 11 June 2026. Subsequently, Ms. Vandan Vij Sarkar resigned from the office of Director of the Company with effect from 24 August 2026.
14. REMUNERATION OF DIRECTORS AND EMPLOYEES OF THE COMPANY:
The information required under Section 197(12) of the Companies Act, 2013 read with Rule 5(1) of Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 in respect of Directors/employees of the Company is set out in Annexure - I of this report.
15. HUMAN RESOURCES:
The relations with the employees and associates continued to remain cordial throughout the year. The Directors of your Company wish to place on record their appreciation for the excellent team spirit and dedication displayed by the employees of the Company.
16. MEETINGS OF BOARD OF DIRECTORS:
The Board of directors duly met 17 (Seventeen) times. Details of the Board Meeting of the Company Following below:
| S.no | Date of BM | Name of Director | ||||||
| San tan u Sarkar | Vedan t sarkar | Brahm a Ghosh Raval | Sruti Chand a | Preet y Priya ghosh | Gaura V Mittal | Kaushikkum ar Vasantbhai Darji | ||
| 1. | 21.04.2025 | V | V | V | V | V | N.A. | N.A. |
| 2. | 31.05.2025 | V | V | V | V | V | N.A. | N.A. |
| 3. | 01.07.2025 | V | V | N.A. | V | V | N.A. | N.A. |
| 4. | 02.07.2025 | V | V | N.A. | V | V | N.A. | N.A. |
| 5. | 19.08.2025 | V | V | N.A. | V | V | N.A. | N.A. |
| 6. | 06.09.2025 | V | V | N.A. | V | V | N.A. | N.A. |
| 7. | 23.09.2025 | V | V | N.A. | N.A. | V | V | V |
| 8. | 25.09.2025 | V | V | N.A. | N.A. | V | V | V |
| 9. | 29.09.2025 | V | V | N.A. | N.A. | V | V | V |
| 10. | 31.12.2025 | V | V | N.A. | N.A. | V | V | V |
| 11. | 09.01.2026 | V | V | N.A. | N.A. | V | V | V |
| 12. | 13.01.2026 | V | V | N.A. | N.A. | V | V | V |
| 13. | 16.01.2026 | V | V | N.A. | N.A. | V | V | V |
| 14. | 20.01.2026 | V | V | N.A. | N.A. | V | V | V |
| 15. | 22.01.2026 | V | V | N.A. | N.A. | V | V | V |
| 16. | 11.02.2026 | V | V | N.A. | N.A. | V | V | V |
| 17. | 09.03.2026 | V | V | N.A. | N.A. | V | V | V |
17. MEETING OF SHAREHOLDERS:
| Sr. No. | General Meeting Date / Postal Ballot | Type of Meeting |
| 1 | 15.04.2025 | Extra ordinary General Meeting |
| 2 | 24.07.2025 | Annual General Meeting |
| 3 | 08.09.2025 | Extra ordinary General Meeting |
| 4 | 13.01.2026 | Extra ordinary General Meeting |
18. DECLARATION BY INDEPENDENT DIRECTORS:
Pursuant to the provisions of Section 134(3)(d) read with Sections 149(6) and 149(7) of the Companies Act, 2013, the Company has received the necessary declarations from all the Independent Directors confirming that they continue to meet the criteria of independence prescribed under Section 149(6) of the Companies Act, 2013 and Regulations 16(1) (b) and 25 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations). The Independent Directors have further confirmed that there has been no change in the circumstances affecting their status as Independent Directors of the Company.
The Independent Directors have complied with the Code for Independent Directors as prescribed under Schedule IV to the Companies Act, 2013 and the Companys Code of Conduct for the Board of Directors and Senior Management Personnel.
All the Independent Directors of the Company have registered their names in the Independent Directors Databank maintained by the Indian Institute of Corporate Affairs (IICA), in accordance with the applicable provisions of the Companies Act, 2013 and the rules made thereunder. The online proficiency self-assessment test, wherever applicable, has been or will be undertaken by the Independent Directors within the prescribed timelines, except by those who are exempt under the applicable provisions. In the case of Mr. Sukhomoy Das, who has recently enrolled in the Independent Directors Databank, the period of one year available under the applicable provisions for passing the online proficiency self-assessment test has not yet expired. Accordingly, he remains within the prescribed timeline for completing the said test.
The Company has adopted a Code of Conduct for the Board of Directors and Senior Management Personnel, which is available on the Companys website at
https:/ / biopolchemicals.com/ policies/ .
In the opinion of the Board, all the Independent Directors possess the requisite integrity, expertise, experience and proficiency, fulfil the conditions specified under the Companies Act, 2013, the SEBI Listing Regulations and other applicable laws, and are independent of the management of the Company.
19. FAMILIARIZATION PROGRAMME FOR INDEPENDENT DIRECTORS:
The Independent Directors are provided with necessary documents/ brochures, reports and internal policies to enable them to familiarize with the Companys procedures and practices, the website link is https://biopolchemicals.com/.
20. BOARD COMMITTEES:
The Board has constituted the Audit Committee, Nomination and Remuneration Committee and Stakeholders Relationship Committee in accordance with the provisions of the Companies Act, 2013 (the Act) and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations).
During the year under review, the composition of the Board underwent changes pursuant to the appointment of Mr. Kaushikkumar Vasantbhai Darji and Mr. Gaurav Mittal as Additional Independent Directors with effect from September 6, 2025, the resignation of Mr. Brahma Ghosh Rawal, Independent Director, with effect from May 31, 2025, the resignation of Ms. Sruti Chanda, Independent Director, with effect from September 6, 2025, and the resignation of Ms. Preety Priya Ghosh, Independent Director, with effect from March 18, 2026.
Consequent to the resignation of Ms. Preety Priya Ghosh, Independent Director, the composition of the Audit Committee and the Nomination and Remuneration Committee was not in compliance with the requirements of the Act and the SEBI Listing Regulations as on March 31, 2026, on account of the resultant vacancy in the office of an Independent Director. However, the composition of the Stakeholders Relationship Committee continued to remain in compliance with the applicable provisions of the Act and the SEBI Listing Regulations.
Subsequent to the close of the financial year, the Board appointed Ms. Vandan Vij Sarkar as a Non-Executive Non-Independent Director and Mr. Sukhomoy Das as an Additional Independent Director with effect from June 11, 2026. Consequent upon the appointment of Mr. Sukhomoy Das, the Audit Committee and the Nomination and Remuneration Committee were duly reconstituted, thereby restoring compliance with the applicable provisions of the Act and the SEBI Listing Regulations. Subsequently, Ms. Vandan Vij Sarkar resigned from the office of Non-Executive Non-Independent Director with effect from 24 August 2026.
The vacancy arising from the resignation of Ms. Preety Priya Ghosh was filled within the timeline prescribed under the applicable laws.
20.1. Audit Committee:
The Audit Committee was originally constituted by the Board on July 1, 2024 pursuant to the provisions of Section 177 of the Companies Act, 2013 read with the Companies (Meetings of Board and its Powers) Rules, 2014 and Regulation 18 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
During the financial year 2025-26, the composition of the Audit Committee underwent a change consequent to the resignation of Ms. Preety Priya Ghosh, Independent Director, on March 18, 2026. Subsequently, Mr. Sukhomoy Das was appointed as an Additional Independent Director on June 11, 2026, and his appointment is being placed for shareholders approval at the ensuing Annual General Meeting by way of a Special Resolution. Accordingly, the composition of the Audit Committee shall be in compliance with the applicable provisions for the F.Y. 2026-27.
The composition of the Audit Committee as on March 31, 2026 was as under:
| Name of the Directors | Nature of Directorship | Designation in Committee |
| Gaurav Mittal | Non-Executive Independent Director | Chairman |
The Company Secretary acts as the Secretary to the Audit Committee.
The terms of reference, powers and role of the Audit Committee are in accordance with the provisions of Section 177 of the Companies Act, 2013 and Regulation 18 read with Part C of Schedule II of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Chairperson of the Audit Committee attends the Annual General Meeting to respond to shareholders queries relating to financial statements and other matters within the Committees scope.
During the year, the Committee met six (6) times.
20.2. Nomination and Remuneration Committee:
The Nomination and Remuneration Committee was originally constituted by the Board on July 1, 2024 pursuant to the provisions of Section 178 of the Companies Act, 2013 read with the Companies (Meetings of Board and its Powers) Rules, 2014 and Regulation 19 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
During the financial year 2025-26, the composition of the Nomination and Remuneration Committee underwent a change consequent to the resignation of Ms. Preety Priya Ghosh, Independent Director, on March 18, 2026. Subsequently, Mr. Sukhomoy Das was appointed as an Additional Independent Director on June 11,2026, and his appointment is being placed for shareholders approval at the ensuing Annual General Meeting by way of a Special Resolution. Accordingly, the composition of the Nomination and Remuneration Committee shall be in compliance with the applicable provisions for the F.Y. 2026-27.
The composition of the Nomination and Remuneration Committee as on March 31, 2026 was as under:
| Name of the Directors | Nature of Directorship | Designation in Committee |
| Gaurav Mittal | Non-Executive Independent Director | Member |
| KaushikKumar Vasantbhai Dar)i | Non-Executive Independent Director | Member |
The Company Secretary acts as the Secretary to the Nomination and Remuneration Committee.
The terms of reference of the Committee are in accordance with the provisions of Section 178 of the Companies Act, 2013 and Regulation 19 read with Part D of Schedule II of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
During the year, the Committee met one (1) time.
20.3. Stakeholders Relationship Committee:
| KaushikKumar Vasantbhai Darji | Non-Executive Independent Director | Member |
bn i ? p cm L
The Stakeholders Relationship Committee was originally constituted by the Board on July 1, 2024 pursuant to the provisions of Section 178 of the Companies Act, 2013 read with the Companies (Meetings of Board and its Powers) Rules, 2014 and Regulation 20 of the SEBI Listing Regulations. Consequent to the changes in the composition of the Board, the Committee was reconstituted by the Board at its meeting held on September 6, 2025.
The composition of the Stakeholders Relationship Committee as on March 31, 2026 was as under:
| Name of the Directors | Nature of Directorship | Designation in Committee |
| Mr. KaushikKumar Vasantbhai Darji | Non-Executive Independent directors | Chairperson |
| Mr. Gaurav Mittal | Non-Executive Independent directors | Member |
| Mr. Vedant Sarkar | Whole-time Director | Member |
The Company Secretary acts as the Secretary to the Stakeholders Relationship Committee.
The terms of reference of the Committee are in accordance with the provisions of Section 178 of the Companies Act, 2013 and Regulation 20 read with Part D of Schedule II of the SEBI Listing Regulations.
During the year, the Committee met one (1) time.
21. AUDIT COMMITTEE RECOMMENDATIONS:
During the year, all recommendations of Audit Committee were approved by the Board of Directors.
22. COMPANY POLICIES:
The Board of Directors of your Company, from time to time have framed and revised various Polices as per the applicable Acts, Rules, Regulations and Standards for better governance and administration of the Company. The Policies are made available in the Investors Section on the website of the Company at https: / /biopolchemicals.com/policies/ . The policies are reviewed periodically by the Board and updated based on need and requirements.
23. NOMINATION AND REMUNERATION POLICY:
The Company believes that building a diverse and inclusive culture is integral to its success. A diverse Board, among others, will enhance the quality of decisions by utilizing different skills, qualifications, professional experience and knowledge of the Board members necessary for achieving sustainable and balanced development. In terms of SEBI Listing Regulations and Act, the Company has in place Nomination & Remuneration Policy.
The said policy of the Company, inter alia, provides that the Nomination and Remuneration Committee shall formulate the criteria for appointment of Executive, Non-Executive and Independent Directors on the Board of Directors of the Company and persons in the Senior Management of the Company, their remuneration including determination of qualifications, positive attributes, independence of directors and other matters as provided under subsection (3) of Section 178 of the Act (including any statutory modification(s) or re-enactment(s) thereof for the time being in force). The Policy also lays down broad guidelines for evaluation of performance of Board as a whole, Committees of the Board, individual directors including the chairperson and the Independent Directors. The aforesaid Nomination and Remuneration Policy has been uploaded on the website of your Company:
https; / / biopolchemicals.com/ policies/ .
24. RISK MANAGEMENT:
The Board periodically reviews the risks associated with the business of the Company and the adequacy of the measures taken to mitigate them. Being listed on the SME Platform, the Company is not required to constitute a Risk Management Committee under Regulation 21 of the SEBI (LODR) Regulations, 2015. Nevertheless, the Board of the Company has evaluated a risk management to monitor the risk management plan for the Company. The Audit Committee has additional oversight in the area of financial risk and controls. Major risks identified by the businesses and functions are systematically addressed through mitigating actions on continuing basis.
25. VIGIL MECHANISM AND WHISTLE BLOWER POLICY:
The Company has established Vigil Mechanism for Directors and employees to report their genuine concerns about unethical behavior, actual or suspected fraud or violation of the Companys Code of Conduct and provide adequate safeguard against their victimization as provided in Section 177 of the Companies Act, 2013 and rules made there under. The Company promotes ethical behaviour in all its business activities and in line with the best governance practices.
The Whistle Blower Policy aims to:
• allow and encourage stakeholders to bring to the managements notice concerns about unethical behavior;
• ensure timely and consistent organisational response;
• cultivate and fortify a culture of transparency and trust; and
• provide protection against victimisation.
In accordance with the provisions of Section 177(9) of the Act, read with Rule 7 of the Companies (Meeting of the Board and its Powers) Rules, 2014 and Regulation 22 of the Listing Regulations, the Directors and the employees have direct access to the Chairman as well as the Members of the Audit Committee. No person was denied access to the Audit Committee.
Vigil Mechanism and Whistle Blower Policy is available on the website of the Company at
https:/ /biopolchemicals.com/policies/
All the Board Members and the Senior Management personnel have confirmed compliance with the Code.
26. CORPORATE SOCIAL RESPONSIBILITY (CSR):
The Company remains committed to discharging its Corporate Social Responsibility (CSR) in a responsible and sustainable manner, with a focus on contributing towards the socioeconomic development of the communities in which it operates. The Companys CSR initiatives are undertaken in accordance with the provisions of Section 135 of the Companies
bn i ? p cm L
Act, 2013 read with Schedule VII thereto and the Companies (Corporate Social Responsibility Policy) Rules, 2014.
During the financial year under review, the Company incurred CSR expenditure of Rs. 7.50 lakh in accordance with the applicable provisions of the Act. (Refer Note 44 to the Financial Statements.)
As the amount required to be spent by the Company towards CSR activities during the financial year did not exceed Rs. 50 lakhs, the Company was not required to constitute a Corporate Social Responsibility Committee in terms of Section 135(9) of the Companies Act, 2013.
Further, the provisions relating to impact assessment of CSR projects under Rule 8(3) of the Companies (Corporate Social Responsibility Policy) Rules, 2014 were not applicable to the Company during the financial year under review.
The Annual Report on CSR activities, containing the brief outline of the CSR Policy and the details of the CSR initiatives undertaken during the year, is annexed to this Report as Anuexure - II and forms an integral part of this Annual Report. The CSR Policy of the Company is available on the Companys website at https://biopolchemicals.com/policies
27. PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS UNDER SECTION 186 OF THE COMPANIES ACT, 2013:
The details of loans, guarantees or investments covered under Section 186 of the Companies Act, 2013 are given in the Note to the Financial Statements.
28. PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES:
During the FY 2025-26, Company has entered into some transactions with related parties as defined under Section 2(76) of the Companies Act, 2013, which were in the ordinary course of business and at arms length basis. Further, the transactions were in accordance with the provisions of the Companies Act, 2013, read with rules framed thereunder and the SEBI (LODR) Regulations, 2015. All transactions with related parties were entered with prior approval of the Audit Committee.
The details of the related party transactions as required under AS - 18 are set out in Notes- 29 to the financial statements.
The Company has formulated a policy on related party transactions, the policy on materiality of Related Party Transactions and dealing with same is available on Companys website at
https://biopolchemicals.com/policies/ .
The detail disclosure of these transactions in Form AOC- 2 pursuant to Section 134 (3) (h) of the Companies Act, 2013 read with Rule 8(2) of the Companies (Accounts) Rules, 2014 is set out as Anuexure - III to this Report.
29. EVALUATION OF THE PERFORMANCE OF THE BOARD, COMMITTEES AND INDIVIDUAL DIRECTORS:
Pursuant to the provisions of the Companies Act, 2013 the Board has carried out the annual evaluation of the performance of the Board as a whole, Individual Directors including Independent Directors, Non-Independent Directors, Chairperson and the Board Committees. A structured questionnaire was prepared after taking into consideration the inputs received from the Directors, covering various aspects of the Boards functioning such as adequacy of the composition of the Board and its Committees, Meetings of the board, functioning of the board, effectiveness of board processes, Board culture, execution and performance of specific duties, obligations and governance. The exercise was also carried out to evaluate the performance of individual Directors including the Chairman of the Board, who were evaluated on parameters such as level of engagement and contribution, independence of judgment, safeguarding the interest of the Company and its minority shareholders etc.
The performance evaluation of the Independent Directors was carried out by the entire Board excluding the director being evaluated. The performance evaluation of the Chairman and the Non-Independent Directors was carried out by the Independent Directors who also reviewed the performance of the Key Managerial Personnel. The Directors expressed their satisfaction with the evaluation process.
30. TRANSFER OF AMOUNTS TO INVESTOR EDUCATION AND PROTECTION FUND (IEPF):
During the period under review the provisions relating to the Investor Education and Protection Fund (IEPF) is not applicable to the company.
31. DISCLOSURES RELATING TO HOLDING, SUBSIDIARY, ASSOCIATE COMPANY AND JOINT VENTURES:
During the financial year 2025-26, the Company did not have any subsidiary, joint venture or associate company.
32. CODE OF CONDUCT FOR PREVENTION OF INSIDER TRADING:
In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has adopted a Code of Practices and Procedures for fair disclosure of Unpublished Price Sensitive Information and Prohibition of Insider Trading Policy to preserve the confidentiality of Unpublished Sensitive information (UPSI) and to prevent misuse of such information.
The Trading Window is closed when the Compliance Officer determines that a designated person or class of designated persons can reasonably be expected to have possession of Unpublished Price Sensitive Information. All Board of Directors and the designated employees have confirmed compliance with the Code.
33. LISTING FEES:
The listing fees payable for the Financial Year 2025-26 has been paid to National Stock Exchange Limited (NSE) within due date.
34. DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS IMPACTING THE GOING CONCERN STATUS AND THE COMPANYS OPERATIONS IN THE FUTURE:
During the year under review, there have been no such significant and material orders passed by the regulators or courts, or tribunals impacting the going concern status and the companys operations in the future.
35. AUDITORS:
35.1. Statutory Auditors:
Pursuant to the provisions of Section 139 of the Act read with rules thereunder, the shareholders of the Company at the 1st AGM held on September 16, 2024, approved appointment of M/s M B Jajodia & Associates, Chartered Accountants (ICAI Firm Registration Number 0139647W) as the Statutory Auditors of the Company for a term of 5 consecutive years commencing from the conclusion of 1st AGM till the conclusion the 6th AGM of the Company i.e., from FY 2024-25 to FY 2028-29.
M/s. M B Jajodia & Associates, have confirmed that they are within the limits specified under Section 141(3)(g) of the Companies Act, 2013 and they are not disqualified to act as Statutory Auditors in terms of the provisions of Sections 139 and 141 of the Companies Act, 2013 and the Companies (Audit and Auditors) Rules, 2014.
As required under Regulation 33(l)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, M/s. M B Jajodia & Associates., have confirmed that they hold a valid certificate issued by the Peer Review Board of the Institute of Chartered Accountants of India.
The Statutory Auditors Report to the shareholders for the year under review does not contain any modified opinion or qualifications and the observations and comments given in the report of the Statutory Auditors Notes to accounts are self-explanatory and hence do not call for any further explanation or comments under Section 134(f)(i) of the Companies Act, 2013.
35.2. Secretarial Auditor:
The Board, at its meeting held on 15th April, 2026 has appointed M/s. M.K Chokshi & Associates, Practising Company Secretaries to undertake the Secretarial Audit of the Company for the financial year 2025- 26 pursuant to the provisions of Section 204 of the Companies Act, 2013 read with Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 and the SEBI (LODR) Regulations, 2015 as amended.
The Secretarial Audit Report for the Financial Year 2025-26, prepared in the prescribed Form No. MR-3 pursuant to Section 204 of the Act, is annexed as Annexure - IV and forms an integral part of this Report.
The Secretarial Audit Report does not contain any qualification, reservation and adverse remarks and the comments given by the Secretarial Auditors in their report are selfexplanatory and hence, do not call for any further explanations or comments under Section 204(3) of the Act.
35.3. Internal Auditor:
The Board, at its meeting held on 15th April, 2026, appointed M/s. Nikhar Agarwal & Co., Chartered Accountants, as the Internal Auditor of the Company for FY 2025-26.
36. COST RECORDS AND COST AUDIT:
Maintenance of cost records and requirement of cost audit as prescribed under the provisions of Section 148(1) of the Act, are not applicable for the business activities carried out by the Company.
37. INTERNAL AUDIT & CONTROLS:
During the year, the Company continued to implement their suggestions and recommendations to improve the control environment. Their scope of work includes review of processes for safeguarding the assets of the Company, review of operational efficiency, effectiveness of systems and processes, and assessing the internal control strengths in all areas. Internal Auditors findings are discussed with the process owners and suitable corrective actions taken as per the directions of Audit Committee on an ongoing basis to improve efficiency in operations.
38. FRAUDS REPORTED BY THE AUDITOR:
The auditor of the Company has not reported any fraud to the Board or to the Central Government under Section 143(12) of the Companies Act, 2013.
39. GREEN INITIATIVES:
In compliance with Regulation 36 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Notice of the AGM along with the Annual Report 2025-26 is being sent only through electronic mode to those Members whose email addresses are registered with the Company/Depositories. Members may note that the Notice and Annual Report 2025-26 will also be available on the Companys website https: / /biopolchemicals.com/ .
40. REGISTRAR AND SHARE TRANSFER AGENT:
The share transfer and related activities are being carried out by M/s. Cameo Corporate Services Limited, Registrar and Share Transfer Agent from the following address: M/s. Cameo Corporate Services Limited, Subramanian Building, No. 1 Club House Road, Chennai, Tamil Nadu, 600002, India.
41. COMPLIANCE WITH SECRETARIAL STANDARD:
The Company has complied with Secretarial Standards 1 and 2 issued by the Institute of Company Secretaries of India on Board meetings and General Meetings respectively.
42. MANAGEMENT DISCUSSION AND ANALYSIS REPORT:
The Management Discussion and Analysis Report for the Financial Year 2025-26, as required under the Act and Regulation 34(2)(e) read with Schedule V of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, is annexed as Annexure - V and forms an integral part of this Annual Report.
The Report provides a comprehensive review of the Companys operational and financial performance, industry developments, business outlook, opportunities and risks, segment and product-wise performance, and the adequacy of its internal control systems.
43. CORPORATE GOVERNANCE REPORT:
The Company is committed to maintaining high standards of corporate governance and adheres to the applicable provisions of the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations).
Pursuant to Regulation 15(2) of the SEBI Listing Regulations, the Corporate Governance provisions specified therein are not applicable to companies whose specified securities are listed on the SME Exchange. Accordingly, the Company is not required to comply with the provisions of Regulation 27(2) of the SEBI Listing Regulations relating to Corporate Governance reporting.
However, Regulation 23 of the SEBI Listing Regulations relating to Related Party Transactions became applicable to the Company, as its paid-up equity share capital exceeded ?10 crore and its net worth exceeded ?25 crore as on March 31, 2026.
44. IMPLEMENTATION OF CORPORATE ACTION:
During the year under review, the Company has not failed to implement any Corporate Actions within the specified time limit.
45. THE DETAILS OF APPLICATION MADE OR ANY PROCEEDING PENDING UNDER THE INSOLVENCY AND BANKRUPTCY CODE, 2016 DURING THE YEAR ALONG WITH THEIR STATUS AS OF THE END OF THE FINANCIAL YEAR:
Your Company neither made any application nor any proceeding pending under the Insolvency and Bankruptcy Code, 2016 during the year.
46. DETAILS OF THE DIFFERENCE BETWEEN THE AMOUNT OF THE VALUATION DONE AT THE TIME OF ONE-TIME SETTLEMENT AND THE VALUATION DONE WHILE TAKING A LOAN FROM THE BANKS OR FINANCIAL INSTITUTIONS ALONG WITH THE REASONS THEREOF:
Your Company has not obtained any one-time settlement of loan from the Banks or Financial Institutions.
47. DISCLOSURES AS PER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013:
The Company has adopted a policy for prevention of sexual harassment at the workplace, in line with the requirements of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 (POSH Act). The policy aims to provide protection to employees at workplace and prevent and redress complaints of sexual harassment and for the matters connected and incidental thereto, with the objective of providing safe working environment, where employees feel secure.
An Internal Complaints Committee (ICC) has been duly constituted as per the provisions of the POSH Act to redress complaints regarding sexual harassment at the workplace.
During the financial year under review, the Company has complied with all the provisions of the POSH Act and the rules framed thereunder. Further details are as follow:
| a. | Number of complaints of Sexual Harassment received in the Year | Nil |
| b. | Number of Complaints disposed off during the year | Nil |
| c. | Number of cases pending for more than ninety days | Nil |
48. DIRECTORS RESPONSIBILITY STATEMENT:
In terms of the requirements of Section 134(3)(c) read with Section 134(5) of the Companies Act, 2013, Board of Directors of the Company, hereby state and confirm that:
a) In the preparation of the annual accounts for the financial year ended 31st March, 2026, the applicable accounting standards have been followed and there are no material departures from the same;
b) they have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company as at 31st March,2026 and of the profit and loss of the Company for the financial year ended 31st March,2026;
c) they have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Companies Act, 2013 for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;
d) they have prepared annual accounts on a going concern basis;
e) they have laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and operating effectively; and
f) they have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems are adequate and operating effectively.
49. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS AND OUTGO:
The information required under section 134(3) (m) of the Companies Act, 2013 read with Rule 8(3) of the Companies (Accounts) Rules, 2014.
49.1 Conservation Of Energy
| (i) | the steps are taken or impact the conservation of energy | The Company has taken all the possible measures to conserve energy and utilize available alternate sources of energy. |
| (ii) | the steps were taken by the company for utilizing alternate sources of energy | |
| (iii) | the capital investment in energy conservation equipment | NIL |
49.2 Technology Absorption
| (i) | the efforts made toward technology absorption | NIL |
| (ii) | the benefits derived like product improvement, cost reduction, product development, or import substitution | NIL |
| (iii) | in case of imported technology (imported during the last three years reckoned from the beginning of the financial year) | |
| (a) the details of the technology imported | NIL | |
| (b)the year of import; | NIL | |
| (c) whether the technology has been fully absorbed | NIL | |
| (d) if not fully absorbed, areas where absorption has not taken place, and the reasons thereof | NIL | |
| (iv) | the expenditure incurred on Research and Development | NIL |
49.3 Foreign Exchange Earnings and Outgo
During the FY 2025-26, Company has entered into some transactions with Foreign parties. The details of Foreign Exchange Earnings and Outgo are given in the Notes to the Financial Statements forming part of Annual Report.
(In Lakhs)
| Earnings | 946.63/- |
| Outgo | 35.38/- |
50. LISTING ON EMERGE PLATFORM OF NATIONAL STOCK EXCHANGE (NSE):
The Company has listed its shares on National Stock Exchange of India Limited (NSE) as on 13th of February, 2026. Further the Company is regular in compliances of various clauses and regulations of the Listing Agreement and/or LODR.
51. DETAILS IN RESPECT OF THE ADEQUACY OF INTERNAL FINANCIAL CONTROLS WITH REFERENCE TO THE FINANCIAL STATEMENTS:
The Companys internal control systems are commensurate with the Companys size and nature of the business of the Company with regard to manufacturing enabling it to safeguard assets, and prevent and detect frauds as well as other irregularities. All the transactions are properly authorized recorded and reported to the management. The Management is responsible for Companys internal financial control over financial reporting and the financial reporting process. The Company is following all the applicable Accounting Standards for properly maintaining the books of accounts and reporting financial statement.
52. APPRECIATION:
The Directors wish to place on record their appreciation to the banks to their continued cooperation and support. The Board of Directors also takes the opportunity to acknowledge the dedicated efforts of consultants and all others that have helped the management to run the operations of the company.
Your Board of Directors also takes this opportunity to convey their gratitude and sincere thanks for the co-operation & assistance received from the shareholders. The Board appreciates your confidence and continued support and looks forward for the same in future as well.
For and on behalf of the Board of Directors BIOPOL CHEMICALS LIMITED
Date: 25.08.2026 Place: Ahmedabad
Registered Office: Plot No. 123 & 124, G.I.D.C. Phase-1, Vatva, Vatva Industrial Estate, Ahmedabad, Daskroi, Gujarat, India, 382445.
Corporate Identification Number: L20297GJ2023PLC140117 Website: www.biopolchemicals.com
| SD/- | SD/- |
| Santanu Sarkar | Vedant Sarkar |
| Chairman and Managing Director | Whole-time Director |
| DIN: 01245213 | DIN: 10134523 |
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.